Background: Magnesium plays an essential role in maintaining ocular surface homeostasis and is associated with preventing tear film instability, dry eye, and surface inflammation. The purpose of this study was to evaluate the effect of short-term oral magnesium supplementation on ocular tear film parameters in pregnant women. Methods: This prospective observational clinical study was conducted at the Ophthalmology Clinic of Territory Hospital, Riyadh, Saudi Arabia, between May 2025 and April 2026. Twenty-six pregnant women in the third trimester of pregnancy and aged 20 to 40 years were enrolled. All participants received oral magnesium supplementation once daily for seven consecutive days. Tear film assessments were performed before and after supplementation and included non-invasive tear break-up time (NITBUT), Schirmer test, and tear ferning (TF) test. Statistical analyses were conducted using the Statistical Package for the Social Sciences (SPSS), version 22. A p-value of <0.05 was considered statistically significant. Results: Significant improvements were observed in the median NITBUT (p < 0.001), Schirmer test scores (p = 0.001), and TF test scores (p = 0.043) following magnesium supplementation. Improvements in tear film parameters were observed in most participants, with enhanced NITBUT, Schirmer and TF test values reported in 92%, 81% and 63% of subjects, respectively. Conclusion: Short-term oral magnesium supplementation was associated with significant improvements in tear film stability and tear secretion among pregnant women. These findings suggest that magnesium supplementation may be a beneficial nutritional approach to support ocular surface health and reduce the risk of early dry eye symptoms during pregnancy.